Taken together, this suggests that targeting ALDOA may be an important anti-tumour strategy, particularly in tumours that are reliant upon glycolysis as an energy source, and may enable the concurrent targeting of cancer metabolism and DNA repair. This evidence concerns the gene ALDOA and cancer.